vs
嘉德诺（BTSG）与UGI CORP（UGI）财务数据对比。点击上方公司名可切换其他公司
嘉德诺的季度营收约是UGI CORP的1.7倍（$3.6B vs $2.1B），UGI CORP净利率更高（14.4% vs 2.2%，领先12.2%），嘉德诺同比增速更快（16.3% vs 3.9%），嘉德诺自由现金流更多（$193.9M vs $-155.0M），过去两年嘉德诺的营收复合增速更高（17.4% vs -7.5%）
嘉德诺是美国跨国医疗服务企业，位列美国企业营收榜第15位，总部位于俄亥俄州都柏林。公司主营药品与医疗产品分销，服务覆盖超10万个网点，同时生产手套、手术服、流体管理产品等医用外科用品，还运营着规模位居前列的放射性药物网络。
UGI公司是总部位于美国宾夕法尼亚州普鲁士王市的能源企业，主营天然气与电力配送业务，布局覆盖范围广泛，在美国本土及欧洲地区均拥有成熟运营网络，为当地用户提供稳定可靠的能源配送服务。
BTSG vs UGI — 直观对比
营收规模更大
BTSG
是对方的1.7倍
$2.1B
营收增速更快
BTSG
高出12.4%
3.9%
净利率更高
UGI
高出12.2%
2.2%
自由现金流更多
BTSG
多$348.9M
$-155.0M
两年增速更快
BTSG
近两年复合增速
-7.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $3.6B | $2.1B |
| 净利润 | $77.1M | $297.0M |
| 毛利率 | 11.6% | — |
| 营业利润率 | 3.0% | 22.0% |
| 净利率 | 2.2% | 14.4% |
| 营收同比 | 16.3% | 3.9% |
| 净利润同比 | 381.8% | -20.8% |
| 每股收益（稀释后） | $0.34 | $1.34 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BTSGUGI
| Q4 25 | $3.6B | $2.1B | ||
| Q3 25 | $3.3B | $1.2B | ||
| Q2 25 | $3.1B | $1.4B | ||
| Q1 25 | $2.9B | $2.6B | ||
| Q4 24 | $3.1B | $2.0B | ||
| Q3 24 | $2.9B | $1.2B | ||
| Q2 24 | $2.7B | $1.4B | ||
| Q1 24 | $2.6B | $2.4B |
净利润BTSGUGI
| Q4 25 | $77.1M | $297.0M | ||
| Q3 25 | $55.8M | $-13.0M | ||
| Q2 25 | $28.2M | $-163.0M | ||
| Q1 25 | $29.5M | $479.0M | ||
| Q4 24 | $16.0M | $375.0M | ||
| Q3 24 | $-8.2M | $-273.0M | ||
| Q2 24 | $19.9M | $-48.0M | ||
| Q1 24 | $-45.8M | $496.0M |
毛利率BTSGUGI
| Q4 25 | 11.6% | — | ||
| Q3 25 | 11.8% | — | ||
| Q2 25 | 11.9% | — | ||
| Q1 25 | 11.8% | — | ||
| Q4 24 | 13.8% | — | ||
| Q3 24 | 14.0% | — | ||
| Q2 24 | 14.2% | — | ||
| Q1 24 | 14.3% | — |
营业利润率BTSGUGI
| Q4 25 | 3.0% | 22.0% | ||
| Q3 25 | 2.6% | 1.1% | ||
| Q2 25 | 1.5% | -6.8% | ||
| Q1 25 | 1.8% | 26.6% | ||
| Q4 24 | 2.6% | 24.5% | ||
| Q3 24 | 2.0% | -20.4% | ||
| Q2 24 | 2.3% | 5.0% | ||
| Q1 24 | 0.3% | 29.7% |
净利率BTSGUGI
| Q4 25 | 2.2% | 14.4% | ||
| Q3 25 | 1.7% | -1.1% | ||
| Q2 25 | 0.9% | -12.0% | ||
| Q1 25 | 1.0% | 18.2% | ||
| Q4 24 | 0.5% | 18.9% | ||
| Q3 24 | -0.3% | -22.6% | ||
| Q2 24 | 0.7% | -3.6% | ||
| Q1 24 | -1.8% | 20.6% |
每股收益（稀释后）BTSGUGI
| Q4 25 | $0.34 | $1.34 | ||
| Q3 25 | $0.26 | $-0.08 | ||
| Q2 25 | $0.13 | $-0.76 | ||
| Q1 25 | $0.14 | $2.19 | ||
| Q4 24 | $0.11 | $1.74 | ||
| Q3 24 | $-0.04 | $-1.26 | ||
| Q2 24 | $0.10 | $-0.23 | ||
| Q1 24 | $-0.26 | $2.30 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $88.4M | $251.0M |
| 总债务越低越好 | $2.5B | $6.0B |
| 股东权益账面价值 | $1.9B | $5.0B |
| 总资产 | $6.4B | $15.8B |
| 负债/权益比越低杠杆越低 | 1.34× | 1.19× |
8季度趋势，按日历期对齐
现金及短期投资BTSGUGI
| Q4 25 | $88.4M | $251.0M | ||
| Q3 25 | $140.3M | $335.0M | ||
| Q2 25 | $70.1M | $350.0M | ||
| Q1 25 | $52.3M | $426.0M | ||
| Q4 24 | $61.3M | $240.0M | ||
| Q3 24 | $36.0M | $213.0M | ||
| Q2 24 | $25.0M | $183.0M | ||
| Q1 24 | $58.0M | $263.0M |
总债务BTSGUGI
| Q4 25 | $2.5B | $6.0B | ||
| Q3 25 | $2.5B | $6.5B | ||
| Q2 25 | $2.5B | $5.7B | ||
| Q1 25 | $2.5B | $6.6B | ||
| Q4 24 | $2.6B | $6.6B | ||
| Q3 24 | $2.7B | $6.4B | ||
| Q2 24 | $2.6B | $6.3B | ||
| Q1 24 | $2.6B | $6.7B |
股东权益BTSGUGI
| Q4 25 | $1.9B | $5.0B | ||
| Q3 25 | $1.8B | $4.8B | ||
| Q2 25 | $1.7B | $4.9B | ||
| Q1 25 | $1.7B | $5.0B | ||
| Q4 24 | $1.6B | $4.6B | ||
| Q3 24 | $1.6B | $4.3B | ||
| Q2 24 | $1.6B | $4.7B | ||
| Q1 24 | $1.6B | $4.8B |
总资产BTSGUGI
| Q4 25 | $6.4B | $15.8B | ||
| Q3 25 | $6.0B | $15.5B | ||
| Q2 25 | $5.9B | $15.4B | ||
| Q1 25 | $5.8B | $15.7B | ||
| Q4 24 | $5.9B | $15.4B | ||
| Q3 24 | $5.8B | $15.1B | ||
| Q2 24 | $5.6B | $15.1B | ||
| Q1 24 | $5.7B | $15.6B |
负债/权益比BTSGUGI
| Q4 25 | 1.34× | 1.19× | ||
| Q3 25 | 1.38× | 1.37× | ||
| Q2 25 | 1.45× | 1.17× | ||
| Q1 25 | 1.50× | 1.32× | ||
| Q4 24 | 1.58× | 1.44× | ||
| Q3 24 | 1.65× | 1.48× | ||
| Q2 24 | 1.63× | 1.34× | ||
| Q1 24 | 1.64× | 1.40× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $231.6M | $66.0M |
| 自由现金流经营现金流 - 资本支出 | $193.9M | $-155.0M |
| 自由现金流率自由现金流/营收 | 5.5% | -7.5% |
| 资本支出强度资本支出/营收 | 1.1% | 10.7% |
| 现金转化率经营现金流/净利润 | 3.00× | 0.22× |
| 过去12个月自由现金流最近4个季度 | $394.7M | $282.0M |
8季度趋势，按日历期对齐
经营现金流BTSGUGI
| Q4 25 | $231.6M | $66.0M | ||
| Q3 25 | $107.9M | $90.0M | ||
| Q2 25 | $49.1M | $289.0M | ||
| Q1 25 | $101.6M | $684.0M | ||
| Q4 24 | $90.6M | $164.0M | ||
| Q3 24 | $27.2M | $151.0M | ||
| Q2 24 | $-15.2M | $390.0M | ||
| Q1 24 | $-78.9M | $522.0M |
自由现金流BTSGUGI
| Q4 25 | $193.9M | $-155.0M | ||
| Q3 25 | $92.2M | $-168.0M | ||
| Q2 25 | $24.7M | $67.0M | ||
| Q1 25 | $84.0M | $538.0M | ||
| Q4 24 | $75.3M | $-47.0M | ||
| Q3 24 | $7.2M | $-115.0M | ||
| Q2 24 | $-39.0M | $185.0M | ||
| Q1 24 | $-100.7M | $353.0M |
自由现金流率BTSGUGI
| Q4 25 | 5.5% | -7.5% | ||
| Q3 25 | 2.8% | -14.4% | ||
| Q2 25 | 0.8% | 4.9% | ||
| Q1 25 | 2.9% | 20.4% | ||
| Q4 24 | 2.5% | -2.4% | ||
| Q3 24 | 0.2% | -9.5% | ||
| Q2 24 | -1.4% | 13.7% | ||
| Q1 24 | -3.9% | 14.6% |
资本支出强度BTSGUGI
| Q4 25 | 1.1% | 10.7% | ||
| Q3 25 | 0.5% | 22.1% | ||
| Q2 25 | 0.8% | 16.3% | ||
| Q1 25 | 0.6% | 5.5% | ||
| Q4 24 | 0.5% | 10.6% | ||
| Q3 24 | 0.7% | 22.0% | ||
| Q2 24 | 0.9% | 15.2% | ||
| Q1 24 | 0.8% | 7.0% |
现金转化率BTSGUGI
| Q4 25 | 3.00× | 0.22× | ||
| Q3 25 | 1.93× | — | ||
| Q2 25 | 1.74× | — | ||
| Q1 25 | 3.44× | 1.43× | ||
| Q4 24 | 5.66× | 0.44× | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.76× | — | ||
| Q1 24 | — | 1.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BTSG
| Medicare D | $1.1B | 32% |
| Commercial Insurance | $879.8M | 25% |
| Medicare C | $641.2M | 18% |
| Provider Services | $394.2M | 11% |
| Medicaid | $301.4M | 8% |
| Medicare A | $150.5M | 4% |
| Private And Other | $44.0M | 1% |
| Medicare B | $19.5M | 1% |
| Pharmacy Solutions And Provider Services Segments | $19.0M | 1% |
UGI
暂无分部数据
